联康生物科技集团有限公司（股票代码：00690）于2026年1月2日发布的2025年12月股份变动月报显示，公司本月无新增发行或购回股份，股本状况保持稳定。公司报告期为2025年12月1日至12月31日。
报告期内，公司注册股本维持在5000亿股，面值为每股港币0.01，总额为港币50亿，与上月保持一致。已发行股份总数5,971,228,147股，亦未发生新增发行、购回或注销情况。此外，公司现有多项股份期权计划，尚未有期权行使或失效，相关期权数量保持不变。
截至12月末，公司整体股本规模维持稳定。公司声明，所有股份变动事项均已获董事会正式授权，并遵守香港联合交易所有限公司《上市规则》及相关法律。公告由公司秘书何詠欣女士签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.